Natalia Arenas-Ramirez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Natalia Arenas-Ramirez has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Dilara Sahin
Department of Immunology, University Hospital Zurich, 8091, Zurich, Switzerland
1 shared publication- Onur Boyman
Center for Human Immunology, University of Zurich, Zurich, Switzerland
1 shared publication
Latest Publications
- 23 August 2018
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 75 (22) , 4163-4176
Epigenetic mechanisms of tumor resistance to immunotherapy
The recent impact of cancer immunotherapies has firmly established the ability and importance of the immune system to fight malignancies. However, the intimate interaction between the highly dynamic tumor and immune cells leads to a selection process driven by genetic and epigenetic processes. As the molecular pathways of cancer resistance mechanisms to immunotherapy become increasingly known, novel therapeutic targets are being tested in combination with immune-stimulating approaches. We here review recent insights into the molecular mechanisms of tumor resistance with particular emphasis on epigenetic processes and place these in the context of previous models.
- 23 August 2018
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 75 (22) , 4163-4176
Epigenetic mechanisms of tumor resistance to immunotherapy
The recent impact of cancer immunotherapies has firmly established the ability and importance of the immune system to fight malignancies. However, the intimate interaction between the highly dynamic tumor and immune cells leads to a selection process driven by genetic and epigenetic processes. As the molecular pathways of cancer resistance mechanisms to immunotherapy become increasingly known, novel therapeutic targets are being tested in combination with immune-stimulating approaches. We here review recent insights into the molecular mechanisms of tumor resistance with particular emphasis on epigenetic processes and place these in the context of previous models.